Matches in SemOpenAlex for { <https://semopenalex.org/work/W3156162207> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W3156162207 endingPage "77" @default.
- W3156162207 startingPage "77" @default.
- W3156162207 abstract "The use of convalescent plasma (CP) from individuals recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a promising therapeutic modality for the coronavirus disease 2019 (COVID-19). CP has been in use for at least a century to provide passive immunity against a number of diseases, and was recently proposed by the World Health Organization for human Ebola virus infection. Only a few small studies have so far been published on patients with COVID-19 and concomitant hematological malignancies (HM). The Italian Hematology Alliance on HM and COVID-19 has found that HM patients with COVID-19 clinically perform more poorly than those with either HM or COVID-19 alone. A COVID-19 infection in patients with B-cell lymphoma is associated with impaired generation of neutralizing antibody titers and lowered clearance of SARS-CoV-2. Treatment with CP was seen to increase antibody titers in all patients and to improve clinical response in 80% of patients examined. However, a recent study has reported impaired production of SARS-CoV-2-neutralizing antibodies in an immunosuppressed individual treated with CP, possibly supporting the notion of virus escape, particularly in immunocompromised individuals where prolonged viral replication occurs. This may limit the efficacy of CP treatment in at least some HM patients. More recently, it has been shown that CP may provide a neutralising effect against B.1.1.7 and other SARS-CoV-2 variants, thus expanding its application in clinical practice. More extensive studies are needed to further assess the use of CP in COVID-19-infected HM patients." @default.
- W3156162207 created "2021-04-26" @default.
- W3156162207 creator A5007902071 @default.
- W3156162207 creator A5008699357 @default.
- W3156162207 creator A5009381933 @default.
- W3156162207 creator A5051037168 @default.
- W3156162207 creator A5051915793 @default.
- W3156162207 date "2021-01-01" @default.
- W3156162207 modified "2023-10-14" @default.
- W3156162207 title "Therapeutic Use of Convalescent Plasma in COVID-19 Infected Patients with Concomitant Hematological Disorders" @default.
- W3156162207 doi "https://doi.org/10.2991/chi.k.210403.001" @default.
- W3156162207 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8486975" @default.
- W3156162207 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34820612" @default.
- W3156162207 hasPublicationYear "2021" @default.
- W3156162207 type Work @default.
- W3156162207 sameAs 3156162207 @default.
- W3156162207 citedByCount "7" @default.
- W3156162207 countsByYear W31561622072021 @default.
- W3156162207 countsByYear W31561622072022 @default.
- W3156162207 countsByYear W31561622072023 @default.
- W3156162207 crossrefType "journal-article" @default.
- W3156162207 hasAuthorship W3156162207A5007902071 @default.
- W3156162207 hasAuthorship W3156162207A5008699357 @default.
- W3156162207 hasAuthorship W3156162207A5009381933 @default.
- W3156162207 hasAuthorship W3156162207A5051037168 @default.
- W3156162207 hasAuthorship W3156162207A5051915793 @default.
- W3156162207 hasBestOaLocation W31561622071 @default.
- W3156162207 hasConcept C126322002 @default.
- W3156162207 hasConcept C159047783 @default.
- W3156162207 hasConcept C159654299 @default.
- W3156162207 hasConcept C194409129 @default.
- W3156162207 hasConcept C203014093 @default.
- W3156162207 hasConcept C22889606 @default.
- W3156162207 hasConcept C2522874641 @default.
- W3156162207 hasConcept C2779134260 @default.
- W3156162207 hasConcept C2779261636 @default.
- W3156162207 hasConcept C2779384505 @default.
- W3156162207 hasConcept C3008058167 @default.
- W3156162207 hasConcept C3018027319 @default.
- W3156162207 hasConcept C32611913 @default.
- W3156162207 hasConcept C524204448 @default.
- W3156162207 hasConcept C71924100 @default.
- W3156162207 hasConceptScore W3156162207C126322002 @default.
- W3156162207 hasConceptScore W3156162207C159047783 @default.
- W3156162207 hasConceptScore W3156162207C159654299 @default.
- W3156162207 hasConceptScore W3156162207C194409129 @default.
- W3156162207 hasConceptScore W3156162207C203014093 @default.
- W3156162207 hasConceptScore W3156162207C22889606 @default.
- W3156162207 hasConceptScore W3156162207C2522874641 @default.
- W3156162207 hasConceptScore W3156162207C2779134260 @default.
- W3156162207 hasConceptScore W3156162207C2779261636 @default.
- W3156162207 hasConceptScore W3156162207C2779384505 @default.
- W3156162207 hasConceptScore W3156162207C3008058167 @default.
- W3156162207 hasConceptScore W3156162207C3018027319 @default.
- W3156162207 hasConceptScore W3156162207C32611913 @default.
- W3156162207 hasConceptScore W3156162207C524204448 @default.
- W3156162207 hasConceptScore W3156162207C71924100 @default.
- W3156162207 hasIssue "3" @default.
- W3156162207 hasLocation W31561622071 @default.
- W3156162207 hasLocation W31561622072 @default.
- W3156162207 hasLocation W31561622073 @default.
- W3156162207 hasLocation W31561622074 @default.
- W3156162207 hasOpenAccess W3156162207 @default.
- W3156162207 hasPrimaryLocation W31561622071 @default.
- W3156162207 hasRelatedWork W1678510290 @default.
- W3156162207 hasRelatedWork W1972745941 @default.
- W3156162207 hasRelatedWork W1984647379 @default.
- W3156162207 hasRelatedWork W2090002905 @default.
- W3156162207 hasRelatedWork W2139983200 @default.
- W3156162207 hasRelatedWork W3024236348 @default.
- W3156162207 hasRelatedWork W3109201683 @default.
- W3156162207 hasRelatedWork W3134744114 @default.
- W3156162207 hasRelatedWork W3186836045 @default.
- W3156162207 hasRelatedWork W4205873719 @default.
- W3156162207 hasVolume "3" @default.
- W3156162207 isParatext "false" @default.
- W3156162207 isRetracted "false" @default.
- W3156162207 magId "3156162207" @default.
- W3156162207 workType "article" @default.